VSAM
MRNA icon

Value Star Asset Management’s Moderna MRNA Stock Holding History

Value Star Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34,349
Closed -$6.17M – 35
2022
Q4 		$6.17M Buy
34,349
+8,000
+30% +$1.31M 4.82% 6
2022
Q3 		$3.12B Buy
26,349
+6,254
+31% +$949K 1.82% 10
2022
Q2 		$2.87B Hold
20,095
– – 2.1% 11
2022
Q1 		$3.46B Buy
+20,095
New +$3.38M 1.96% 10

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Value Star Asset Management's MRNA Position: Q2 2024 in Review

Value Star Asset Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 31,249 shares — an estimated $3.33M sold.

Value Star Asset Management first reported a position in MRNA in Q1 2023 and held it in 4 quarters. The position peaked at $6.3M in Q1 2023. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Value Star Asset Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Value Star Asset Management sold 31,249 Moderna shares in Q2 2024, an estimated $3.33M.
  • Value Star Asset Management first reported a position in Moderna in Q1 2023 and held it in 4 quarters.
  • Value Star Asset Management's Moderna position peaked at $6.3M in Q1 2023.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Value Star Asset Management's 13F filing for Q2 2024, filed 25 Jul 2024.